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        Cytochrome P4502E1, the ethanol-inducible form, metabolizes and 
activates a significant number of substrates to more toxic products and the induction 
of CYP2E1 by ethanol is thought to result in increased oxidative stress in hepatocytes. 
One proposed mechanism for this increased oxidative stress is the increased 
production of hydrogen peroxide by CYP2E1 via a so called “uncoupling’’ of its 
NADPH oxidation activity. A main hypothesis of this research is that the main
aldehyde constituent found in Lemongrass, citral, will be able to block the activity of 
CYP2E1, and consequently demonstrate physiological antioxidant properties.  
         The induction of the phase II enzyme is an important process involved in 
cellular oxidative stress response, by which the oxidative toxicants can be eliminated 
or inactivated before they damage the critical cellular macromolecules. Phase II 
detoxifying genes provide protection to the cell against the toxicities of ROS and 
reactive intermediates produced during phase I metabolism. 
          In this research, cell culture, RT-PCR and electrophoresis g l technology 
will be used for monitoring the induction of antioxidant genes by a variety of different 
natural products.
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CHAPTER I 
INTRODUCTION 
 
Recent medical studies have shown that oxidative stress is at the root of a 
number of human diseases such as Parkinson's disease (1), Alzheimer's disease (2) 
and cancer (3) which directly or indirectly relates to most of human illness and death 
in the world. Oxidative stress also contributes to aging in the human body (4) and 
causes many general health problems for humans. The production of reactive oxygen 
species (ROS) in the human body damages components of the cell including DNA (5), 
lipids (6) and proteins (7). ROS are ions or molecules including free radicals, oxygen 
ion or peroxides that can oxidize biological molecules. ROS are formed from a variety 
of biochemical reactions and cellular functions (8), or through exposure to chemicals 
(9). The formation and consumption of free radicals can be balanced by antioxidants 
in the cell. Oxidative stress is caused by an imbalance in rate of formatin and 
consumption of free radicals. In addition, there are some common factors responsible 
for the generation of free radicals such as air pollution (10), sunlight (11) and smoking 
(12). In order to reduce oxidative stress, the body produces antioxidants to neutralize 
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free radicals which otherwise can destroy the human cells. The purpose of this
research is to show that specific compounds in the essential oil of lemongrass and 
the primary aldehyde constituent of lemongrass, citral, have the ability to reduce 
oxidative stress by scavenging ROS and/or by preventing their formation. The 
project also addressed the ability of certain essential oils to induce cellular systems 
that remove ROS in the liver and possibly in other tissues. The hypothesis of this 
paper is that lemongrass oil stimulates phase II drug metabolizing enzym s in the 
human liver and reduces the formation of ROS through inhibition of cytochrome 
P4502E1 activity, which is a monooxygenase enzyme that has been implicated in the 
generation of hydrogen peroxide and superoxide radicals.  
1.1 Cytochrome P450 enzymes 
1.1.1. General overview 
Cytochrome P450 enzymes are most responsible for the metabolism of foreign 
chemicals. Their primary purpose is the hydroxylation of non-polar molecules, and 
making the drug more polar to facilitate their elimination in urine. Cytochrome P450 
enzymes are commonly found in both prokaryotic and eukaryotic cells in nature. In 
eukaryotic cells, the cytochrome P450 enzymes are mostly found in the membrane 
3 
 
of the smooth endoplasmic reticulum and some are found in the mitochondria. The 
cytochrome P450 enzymes work with the reductases which provide the cytochrome 
P450 enzymes the electrons from NADPH and sequentially use FAD and FMN in 
the electron transfer process. The two electrons are transferred to the heme cofactor 
in the active center of cytochrome and the cytochrome transfers two electrons to ne 
of the two oxygen atoms of O2 to produce water molecules(23). The remaining 
oxygen atom from O2 remains coordinated to the iron atom of the heme cofactor in 
an elevated oxidation state. This so called oxo ferryl species is the activated 
intermediate in P450 catalysis. The P450 catalytic cycle is shown in figure1. 
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Figure1. The P450 catalytic cycle. 
 
 
4 
 
1.1.2. The aldehydes: Citral, Citronellal, and Decanal 
 
 
 
 
1.1.2.A. Citral     
Citral (3,7-dimethyl-2,6-octadienal) is an aldehyde that has two isomer , cis 
(neral) and trans (geranial). A variety if edible vegetables and fruits, includ g lemon, 
lime, orange, grapefruit, apricot, tomatoes, celery, and others, have been reported to 
contain significant amounts of aldehyde citral(37). It is commonly found in the citrus 
oils which are common flavor ingredients in foods and beverage products. Citral is 
susceptible by acid-promoted and oxidative degradation and decomposed during 
storage by a series of cyclization and oxidation reactions(36). Moreover, citral is the 
most important constituent of lemongrass oil, containing as much as 75% to 85%(37) 
and it has been reported to exhibit activity as vitamin A antagonist by inhibiting the 
oxidation of retinal to retinoic acid(38).  
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1.1.2.B. Citronellal 
Citronellal (3,7-dimethyloct-6-en-1-al), a mono terpenoid is a main component 
in the mixture of terpenoid chemical compounds that gives the lemon scent 
associated with citronella oil. It is a major isolate in distilled oils from the plants 
cymbopogon, lemon-scented gum, and lemon-scented tea tree. Moreover, citronellal 
has high repellent effect to the insect especially for mosquitoes and also possesses 
antifungal properties(39). 
 
 
 
1.1.2.C. Decanal 
Decanal is a ten-carbon aldehyde which is used in fragrances and flavor, it is a 
naturally occurring compound and is an important component in citrus along with 
octanal, citral, and sinensal(40).  
Essential oils containing aldehydes were selected as potential inhibitors of human 
P450 because prior studies by Raner et al. (41) have shown that the nucleophilic 
attack of a ferric peroxo species at the electropositive carbonyl carbon of aldehyde 
CH3 O
CH3 CH3
Citronellal
CH3 O
Decanal
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forms a transient peroxohemiacetal. The peroxy-hemiacetal intermediate in aldehyde 
deformylation resulted heme modification in CYP450. 
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1.1.3.Aldehyde deformylation 
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Figure2. Aldehyde deformylation scheme showing heme alkylation mechanism 
involved in P450 inactivation by aldehydes. 
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1.2 Cytochrome P4502E1 
Cytochrome P4502E1, the ethanol-inducible form, metabolizes and activates a 
significant number of substrates to more toxic products and the induction of CYP2E1 
by ethanol is thought to result in increased oxidative stress in hepatocytes(15). One 
proposed mechanism for this increased oxidative stress is the increased production of 
hydrogen peroxide by 2E1 via a so called “uncoupling’’ of its NADPH oxidation 
activity. A main hypothesis of this research is that the main aldehyde constitue t 
found in lemongrass, citral is able to block the activity of CYP2E1, and consequently 
demonstrate physiological antioxidant properties. Many studies have been carri d out 
involving inhibition of CYP2E1and the potential beneficial effects related to a 
reduction in the activation of carcinogens or hepatotoxins(32). For example 
Cedarbaun et al. showed NO can effectively inhibite arachidonic acid(AA) toxicity in 
liver cells which express high levels of CYP2E1. They treated pyrazole-induced rat 
hepatocytes with AA in the presence of an inhibitor of nitric oxide synthase, 
L-NG-Nitroarginine Methylester (L-NAME) and added the NO donors 
S-nitroso-N-acetylpenicillamine (SNAP) to increase NO level to demonstrate that NO 
can be hepatoprotective against CYP2E1-dependent toxicity and prevent AA-induced 
oxidative stress(31). In order to demonstrate the inhibition of cytochrome P4502E1 
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activity by these natural products, the Michaelis-Menton model will be used in 
conjunction with a HPLC-based P4502E1 catalytic assay involving the oxidation of 
p-nitrophenol to nitro catechol. 
1.3 Phase II detoxifying genes 
The induction of the phase II enzyme is an important process involved in 
cellular oxidative stress response, by which the oxidative toxicants can be eliminated 
or inactivated before they damage the critical cellular macromolecules(13). Phase II 
detoxifying genes provide protection to the cell against the toxicities of ROS and 
reactive intermediates produced during phase I metabolism(13). Members of the 
phase II type enzymes include histone acetyltransferase-1(HAT-1), choline 
acetyltransferase-1(CHAT-1), histamine N-methyltransferase-1(HNMT-1), Epoxide 
hydrolase-1(EPHX-1), Heme oxygenase-1(HO-1) and NAD(P)H: quinone 
oxidoreductase -1(NQO-1). Each of the corresponding gene products play an 
important role in the cell in quenching ROS and preparing them for elimination. 
Several recent studies have shown that some novel antioxidant chemicals induce the 
synthesis of phase II detoxifying enzymes as a mechanism for increasing the ratio of 
reduced GSH/oxidized GSSG. What appears to be happening is that the transcriptio  
factor Nrf2 is activated by these chemicals, allowing it to stimulate the transcription 
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of a large number of genes in the nucleus. Nrf2 normally binds to the cytoskeleton 
associated protein Keap1 which is located in the cytoplasm(14). When released from 
its complex, Nrf2 enters the nucleus and binds to Antioxidant response 
element(ARE) and regulate the expression and induction of a battery of genes 
encoding detoxifying/chemopreventive proteins, which are activated in response to 
oxidants, xenobiotics, UV light, and radiation(14). The increase of the 
Nrf2-dependent transcription is correlated to the response associated with 
electrophilic chemicals and oxidative stress. According to a recent study, the 
activation of Nrf2 involving several kinases such as MAPKs, PKC and PI3K. For 
example PKC, p38 , JNK, ERK1/2 and Nrf2, all have a role in the induction of 
HO-1 by oxidized LDL in human muscle cells(13). The study showed that MAPK 
pathways played an important role in the Nrf2-regulated phase II gene 
expression(13). The gene product of HO-1 catalyzes the rate-limiting step in h me 
degradation, which is transformation of heme into biliverdin, carbon monoxide, and 
free ion(Fe2+)(15). The importance of HO-1 expression is that it mediates 
antioxidant, anti-inflammatory, and antiapoptotic effects within the cell(16-18). The 
increasing activity of HO-1 correspond to the degradation of the heme moiety which 
is a potential toxic prooxidant. In addition, increased activity of HO-1 generates 
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bilirubin which is an antioxidant with the ability to scavenge peroxy radicals and 
inhibit lipid peroxidation(19-21) (Fig 3). CO is another product generated by the 
HO-1 induction, it has the vasodilatory effects, anti-apoptotic effect, and 
anti-inflammatory effect which are mediated by cGMP(15). As for Fe2+ ion, Ferritin, 
an intracellular iron repository, is induced along with HO-1, therefore ferritin binds 
the unbound iron from heme degradation(15). Cell culture, RT-PCR and 
electrophoresis gel technology will be used for monitoring the induction of 
antioxidant genes by a variety of different natural products. The detoxification of 
foreign substances can be classified into two reaction processes; phase I and phase II. 
For phase I reactions, foreign chemicals are mainly oxidized by cytochrome P450 
(CYP) enzymes to become polarized metabolites. Phase II metabolism involves a 
variety of enzymes that catalyze group transfer reactions of reductive reactions such 
as glutathione S-transferase (GST) and NADPH quinone oxidoreductase (NQO1). 
These enzymes convert the reactive Phase I products to more inert hydrophilic 
products(22).  
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Figure3. Reaction intermediates in the conversion of heme to biliverdin and CO by 
heme oxygenase. 
1.4 Inhibition of Cytochrome P450 3A4 
Cytochrome P450 3A4 belongs to the hepatic endoplasmic-reticulum 
(ER)-anchored P450 family and it is a monotopic hemoprotein with its N-terminus 
embedded in the ER-membrane with the bulk of its structure exposed to the cytosol. 
In addition, cytochrome P450 3A4 is induced through transcriptional activation and 
substrate-mediated stabilization of its degradation(26). Cytochrome P450 3A4 is
abundant in the human liver and mainly expressed in the human liver and intestines. 
The inhibition/induction of CYP3A4 has been reported as a significant reason for 
herb–drug interaction(35). It is responsible for the metabolism of about 60% of the 
drugs in current clinical use and regulated by a variety of hormones which include 
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glucocorticoids, growth hormone, and triiodothyronine. Furthermore, drugs such as 
Phenobarbital, clotrimazole, mifepristone, and rifamycin have been shown to induce 
cytochrome P450 3A4 via a transcriptional upregulation(24,25). 
1.5 Nifedipine 
N
H
OO
CH3CH3
CH3
OO
CH3
N
+
O
-
O
Nifedipine  
In an effort to probe the interactions between P450 3A4 and several different 
essential oils, we developed a method to monitor inhibition of cytochrome P450 3A4 
using nifedipine as a test substrate. 
Nifedipine(4-(2-nitrophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine), 
one of the most potent calcium-channel blockers belonging to the group of 
1,4-dihydropyridines(30), is used in the treatment of a variety of cardiovascular 
disorders such as Raynaud’s phenomenon, hypertension and angina pectoris(27,30).  
Nifedipine is a photolabile compound which undergoes oxidative biotransformation 
in the human body into pharmacologically inactive metabolites(30). It is 
commercially available as yellow crystals with a melting point of 172 to 174ºC(27). 
Nifedipine, a highly non-polar compound, has very low solubility therefore it was first 
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dissolved in methanol to facilitate delivery in the current study. In the human body, 
nifedipine is absorbed completely from the gastrointestinal tract and mostly fr m 
jejunum. After absorption, nifedipine is further metabolized in the small intestie and 
liver to form more polar compounds which enable the kidney to eliminate it via the 
urine(30). The first analytical instrumental method to detect nifedipine in biologica  
fluids level is gas chromatographic(GC). The disadvantage of GC is that it lacks 
specificity and selectivity even though the amounts of volumes are in the level of 
micro liter and the limit of detection could go as low as 2ng/ml. In addition, most GC 
methods require liquid-liquid and solid-phase extraction which increases the 
complexity and time required for analysis. Therefore, in order to improve the 
sensitivity, specificity, and efficiency, a high performance liquid 
chromatographic(HPLC) method has been developed to detect nifedipine in plasma, 
however, many of these methods still involved complicated and time-consuming 
sample extraction. So a major goal has been to determine the plasma level of
nifedipine to yield a reliable estimate of its pharmacokinetic parameters for 
therapeutic drug monitoring and bioavailability/bioequivalence purposes. These 
estimates rely on the ability to measure the drug level at the lower end of the plasma 
concentration range found in pharmacokinetic studies following the administration of 
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therapeutic doses of the drug(30). The method described in this thesis allows rapid 
accurate measurements of oxidized nifedipine. 
1.6 Oxidized Nifedipine 
N
CH3O
O
CH3
CH3
OO
CH3
N
+
O
-
O
Oxidized Nifedipine  
Oxidized Nifedipine is the metabolite of Nifedipine which is formed by CYP3A4 
in the oxidation reaction of nifedipine. In my research, nifedipine is used as the 
substrate for testing the metabolism and inhibition of CYP3A4 activities and the 
metabolic analysis is performed by Shimadzu HPLC. The structure of oxidized 
nifedipine is shown above. 
 
1.7 HepG2 human liver cells  
In my research, the Hepg2 human liver cancer cell line was used for the cell 
culture.  Many publications indicate that liver cell lines have the activities of drug 
metabolizing enzymes involved in the activation and detoxification of genotoxic 
carninogens. In addition, liver cell lines show more pronounced DNA damaging 
effects caused by test substances than stable mammalian cel li es(29). Among these 
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cell lines, human HepG2 cell line is the most promising one which has been used in a 
number of genotoxicity tests. The HepG2 cells possess different phase I and phase II 
enzymes involved in the activation/detoxification of genotoxic carcinoge s(29) and 
HepG2 cell line is very valuable for the screening purposed in the early phase of 
pharmaceutical development(28). 
1.8 Proposed research 
The following two projects were initiated in order to probe the potential 
antioxidant mechanisms associated with essential oil of lemongrass. 
Project 1: To establish the mechanism and potency of inhibition of human 
cytochrome P4502E1 and P4503A4 by essential oil of lemongrass and the primary 
aldehyde constituent of lemongrass, citral. According to preliminary studies, 
lemongrass has promising inhibitory properties toward P4502E1 in vitro. The major 
aldehyde component of lemongrass (citral) appears to be the primary inhibitory 
constituents of that oil. The experimental method to be used is a HPLC-based assay 
in which p-nitrophenol(PNP) is oxidized by cytochrome P4502E1 by human liver 
tissue in the presence of the essential oil of Lemongrass o  its major constituents. A 
similar approach using Nifedipine oxidation reaction will be used to show the 
analogous effects on P4503A4.  
17 
 
Project 2: To show induction of antioxidant genes by essential oil of lemongrass 
and primary aldehyde constituent of lemongrass, citral, and to identify those 
constituents responsible for induction. The hypothesis of this objective is that the 
Lemongrass aldehyde constituent, citral, can activate the antioxidant respons  
elements found in a variety of antioxidant /phase II drug metabolizing genes. 
Cultured human liver cells ( HepG2 ) will be used to test this hypothesis where cells 
will be treated with oil or aldehyde and RT-PCR will be used to monitor antioxidant 
gene expression. 
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CHAPTER II  
MATERIALS AND METHODS 
 
2.1 CYP2E1 by lemongrass and other essential oils 
Several different essential oils along with purified aldehyde constituents were 
tested for their abilities to inhibit P4502E1. In particular Citral, Nonenal, Nonyl 
aldehyde, Citronellal and Decanal were evaluated with the oils Lemongrass, 
Eucalyptus Globulous, Cassia, Citronella and Eucalyptus lemon. The following 
experimental procedure was used for the evaluation of P4502E1 inhibition: 5ul of the 
oil or aldehyde was diluted to 100ml in deionized water and this solution, along with 
20ul of microsomes, 50ul of 1M potassium phosphate buffer solution (pH 7.4), 50mM 
p-nitrophenol(PNP) and deionized water were combined in a final volume of 0.5ml. 
25ul of 1mM NADPH was added to initiate the reaction in a 37oC water bath for 1 hr, 
then the reaction was quenched with the addition of 200ul of 6% perchloric acid. 
Samples were incubated in an ice bath for 10 minutes then centrifuged at 4000 rpm 
for 10 minutes and 400ul of supernatant was transferred to HPLC vials and analyzed 
by HPLC(SHIMADZU) for product formation. The product of p-nitrophenol 
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oxidation, nitrocatechol, was monitored using a Shimadzu LC 20A Series HPLC 
system consisting of an SPD-20A UV/Vis detector, LC 20AT solvent delivery, and a 
Sil 20A autosampler, all controlled using the Shimadzu EZStart version 7.3 SP1 
software package. Absorbance detection was set to 340 nm with a mobile phase 
consisting of 35% acetonitrile, 64.5% H2O, 0.5% acetic acid. The volume of 
injection is 40 ul for each sample and the column used was a RP-C18 HPLC column. 
For the CYP2E1 assay, total oil content in the experiments ranged from 0.5 mg/ml 
up to 37 mg/ml. Graphical analysis of the Michaelis-Menten data was processed 
using the non-linear regression analysis function of Slidewrite version 4.1 (advance 
Graphics Software Inc), in order to generate KI values for each of the inhibitors used. 
All assays were carried out in duplicate and repeated at least twice giving a 
minimum of four independent experimental values that could be averaged. The 
Lemongrass oil was purchased from Birch Hill Happenings Aromatherapy, LLC and 
the aldehyde citral, 95%, mixture of cis-Citral and trans-Citral, was purchased from 
ACROS ORGANICS.  
2.2 Growth and treatment of HepG2 cells 
HepG2 cells were grown in 75 cm2 tissue culture flasks at 37oC 5% CO2 under 
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standard conditions: (Dulbecco's Modified Eagle Medium(DMEM) 1X with 1g/L 
glucose, 584 mg/L L-glutamine & 110 mg/L sodium pyruvate+ 10% Fetal bovine 
serum). When the cells were about 80% confluency, they were treated with iluted 
essential oils at concentrations between 20ug/ml and 200ug/ml for 5h. The cells were 
then treated with DMEM containing trypsin and incubated in the 37oC environment 
for 5 minutes until they separated from the flask. Following this incubation, cells were 
harvested by scraping from the plate and were collected in a 15ml Falcon tube. The 
samples were then subjected total RNA isolation which is describ d in the following 
section. 
2.2.1 Total RNA isolation and RT-PCR analysis 
The RNA of the cells was isolated by using the SV Total RNA Isolation 
System protocol which includes disrupting the cells, denaturing the nucleoprotein 
complexes, inactivation of the RNase activity and removal of the proteins and DNA. 
The protocol used was as follows: In the RNA isolation section, 1. 175ul cell lysate 
was placed into the centrifuge tube then 350ul of SV RNA Dilution Buffer was 
added. The sample was mixed by inverting the tube 3~4 times and centrifuged at 
14000g for 10 minutes at room temperature.  2. The cleared lysate solution was 
transferred to a fresh microcentrifuge tube by pipeting, while avoiding disturbing the 
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pelleted debris. A 200ul 95% ethanol aliquot was added to the cleard lysate and 
mixed by pipeting 3-4 times. This mixture was transferred to a spin column 
assembly and centrifuged for one minute at 14000g. 3. The spin basket was removed 
from the spin column assembly and the liquid in the collection tube was discarded. 
The spin basket was placed back into the collection tube, and 600ul of SV RNA 
Wash Solution was added to the spin column assembly then centrifuged at 14000g 
for one minute. 4. The collection tube was emptied as before and set in a rack. The 
DNase incubation mix was prepared by combining 40ul yellow core buffer, 5ul 
0.09M MnCl2 and 5ul of DNase I enzyme, per sample, in a sterile tube (in this order). 
The DNase incubation mix was disbursed by gentle pipeting. A 50ul aliquot of 
freshly prepared DNase incubation mix was applied directly to the membrane insid  
the spin basket for 15minutes incubation at the room temperature. 5. After the 
incubation, 200ul of SV DNase Stop Solution was added to the spin baset and 
centrifuged at 14000g for one minute. Then 600ul SV RNA Wash Solution (with 
ethanol added) was added and centrifuged at 14000g for one minute. 6. Th  
collection tube was emptied and 250ul SV RNA Wash Solution (with ethanol added) 
was added and the assembly was then centrifuged at 14000g for two minutes. 
Finally, 100ul Nuclease-Free Water was added to the membrane and centrifuged for 
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one minute to elute the RNA and stored at -70 oC. A 10 ul sample of the RNA was 
used for reverse transcription to the corresponding cDNA, as described in the 
protocol provided with the kit. 
2.2.2 RT-PCR  
The cDNA obtained from the previous step was used as a template for PCR 
reactions, which were performed in a final volume of 20 µl according to the 
specifications given with the DNA polymerase. The cycling conditions wereas 
follows: mixtures were heated to 95 °C for 5 min and then cycled 35 times through a 
30 sec denaturation step at 95 °C, a 1 min annealing step at a specified annealing 
temperature 54°C-62°C, and a 45 sec extension step at 72 °C in a Perkin Elmer 9600 
DNA cycler (Wellesley, MA). A 4.0 min extension time at 72 °C was included at the 
end of 35 cycles, and this was followed by incubation at 4 °C until the samples were 
analyzed. All PCR products were separated by gel electrophoresis on a 1.5%garose 
gel, prepared by dissolving 0.6g agarose into 35ml 1xTAE buffer. A 10ul aliquot of 
each RT-PCR was mixed with 5ul 5X loading buffer and the samples were 
electrophoresed at 120V until the bromophenol blue dye reached the bottom of the 
gel. After running the gel, 50ul of a 0.625mg/ml Ethiudium Bromide solution was 
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added to DI water (100ml) and the gel was placed in this solution for one to two 
hours, and the DNA was visualized on a transilluminator with UV excitation. 
2.2.3 Induction of phase II genes 
2.2.3.1 Determination of effective dose of lemongrass for induction of phase II 
genes 
Primer sets were used to amplify the cDNA of certain phase II mRNA produced 
in the HepG2 cells: the genes of interest consisted of histone 
acetyltransferase-1(HAT-1), choline acetyltransferase-1(CHAT-1), histamine 
N-methyltransferase-1(HNMT-1), Epoxide hydrolase-1(EPHX-1), Heme 
oxygenase-1(HO-1) and NAD(P)H dehydrogenase, quinone-1(NQO-1). These genes 
were selected on the basis of their observed induction upon exposure to Green tea 
extract in a prior study(34). Cells were treated with the essential oils at concentrations 
of 20ug/ml, 50ug/ml, and 200ug/ml. HepG2 cells were grown in 25 cm2 tissue culture 
flasks at 37oC. When the cells reached about 80% confluence, they were treated with 
the essential oils for 5h. The cells were then treated with trypsin and incubated in the 
37oC environment for 5 minutes as described previously. Following this incubation, 
cells were harvested by scraping from the flask. The cells were collected in a 15ml 
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Falcon tube and subjected to total RNA isolation which is described in the previous 
section. Control experiments were carried out using the same conditions, only DI 
water was added in place of the essential oil mixture.  
Table1. The primer sequences and base pairs. 
 
 
 
 
 
 
 
Name        Primer sequence                           Product 
β- actin 1 5’-AGCGAGCATCCCCCAAAGTT-3’ 285bp 
β- actin 2 5’-GGGCACGAAGGCTCATCATT-3 285bp 
CHAT-1 5’-GTCTACGCCTGTGGAGCCGATAC-3’ 255bp 
CHAT-2 5’-GGAACCAAGCTTAGTGGCTGGCAGC-3’ 255bp 
HNMT-1 5’-GGACAAGAAGCTGCCAGGC-3’ 219bp 
HNMT-2 5’-CTCGAGCTTCGATGTCTTGGC-3’ 219bp 
HAT1-1 5’-CAGTTCTCAGTCCAACAGGAGGAG-3’ 215bp 
HAT1-2 5’-CGGTCGCAAAGAGCGTAGCTCCA-3’ 215bp 
EPHX1-1 5’-GGCTTCTCAGAGGCATCCTCC-3’ 273bp 
EPHX1-2 5’-CCACATCCCTCTCAGTGAGGCC-3’ 273bp 
GAPDH1 5’-AGAAGGCTGGGGCTCATTTG-3’ 258bp 
GAPDH2 5’-AGGGGCCATCCACAGTCTTC-3’ 258bp 
HO-1 5’-GCTTCACATAGCGCTGCA-3’ 270bp 
HO-2 5’-CAGGCAGAGAATGCTGAGTTC-3’ 270bp 
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2.2.4 Time dependent induction of phase II genes 
Experiments were also carried out in an attempt to establish the kinetics of 
induction of these genes. To do this, HepG2 cells were treated with lemongrass oil at 
the dose of 20ug/ml, as indicated in the previous section. After treatment, cells were 
grown in 25 cm2 tissue culture flasks at 37oC for additional 0hr, 2hrs, 6hrs and 24hrs. 
The cells were then trypsinized and incubated in the 37oC environment for 5 minutes. 
Following this incubation, cells were harvested by scraping from the flask. The cells 
were collected in a 15ml Falcon tube and subjected to total RNA isolation as 
described in the previous sections. Samples were analyzed by RT-PCR in an attempt 
to determine kinetics of induction. Control experiments were carried out using the 
same conditions, only DI water was added in place of the essential oil mixture.  
2.2.5 Effect of essential oil of Lemongrass on CYP3A4 activity 
As with the 2E1 study, the effect of Lemongrass on CYP3A4 activity was 
determined. A specific assay for monitoring CYP3A4 has been developed utilizing 
the specific ability of this enzyme to oxidize nifedipine. Initially an assay for the 
oxidation of the nifedipine by CYP3A4 had to be developed. Using five different 
types of microsomes; human liver microsomes, rabbit liver microsomes 1, rabbit 
liver microsomes 2, rat liver microsomes, and supersomes enriched in CYP3A4, 
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experiments were carried out in the absence and presence of NADPH. The 
experimental procedure used for the evaluation of CYP3A4 inhibition was as 
follows: Along with 20ul of the five different kinds of microsomes, 50ul of 0.1M 
potassium phosphate buffer solution (pH 7.4), 40ul of 1mM Nifedipine and 
deionized water were initially combined in a final volume of 0.5ml. 25ul of 20mM 
NADPH was added to initiate the reaction in a 37oC water bath for 10 minutes, then 
the reaction was quenched with the addition of 1ml of dichloromethane and 100ul of 
1M Na2CO3 buffer (pH 10.5) containing 2M NaCl. Samples were extracted by 
liquid-liquid extraction then centrifuged at 4000 rpm for 10 minutes and 1ml of 
organic layer was transferred to centrifuge tube, reduced to dryness at 23oC under 
vacuum and 500ul of 45% methanol was added to the centrifuge tube, transferred to 
HPLC vials, and analyzed by HPLC(SHIMADZU) for product formation. The 
product of Nifedipine oxidation, oxidized Nifedipine, was monitored using a 
Shimadzu LC 20A Series HPLC system consisting of an SPD-20A UV/Vis detector, 
LC 20AT solvent delivery, and a Sil 20A autosampler, all controlled using the 
Shimadzu EZStart version 7.3 SP1 software. Absorbance detection was set to 254 
nm with a mobile phase consisting of 60% methanol, 40% H2O, 0.5% acetic acid at 
a flow rate of 0.6ml/min. The volume of injection was 40 ul for each sample and the 
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column was a RP-C18 HPLC column 100cm x 3.0mm. All assays were carried out 
in duplicate. After the trials with five different microsomes, rat liver microsomes 
were chosen to perform the oxidation of the nifedipine by CYP3A4 assay due to the 
greater activity of these microsomes in the oxidation of nifedipine. First, the screen 
experiments of both Lemongrass oil and the aldehyde citral were carried out to 
determine the potency of inhibition of CYP3A4 with 20ul of rat microsomes, 50ul of 
1.0M potassium phosphate buffer solution (pH 7.4), 40ul of 1mM Nifedipine , and 
deionized water were initially combined in a final volume of 0.5ml. 25ul of 20mM 
NADPH was added to initiate the reaction in a 37oC. After establishing the potency 
of inhibition of CYP3A4, Michaelis-Menten plots were used for the evaluation of 
CYP3A4 inhibition by Lemongrass oil and the aldehyde citral. 5ul of the 
Lemongrass oil or the aldehyde citral was diluted to 100ml in deionized water and 
5ul of this solution, along with 20ul of rat microsomes, 50ul of 1.0M potassium 
phosphate buffer solution (pH 7.4), 0.2mM nifedipine and deionized water were 
combined in a final volume of 0.5ml. 25ul of 20mM NADPH was added to initiate 
the reaction in a 37oC water bath for 10 minutes, then the reaction was quenched 
with the addition of 1ml of dichloromethane and 100ul of 1M Na2CO3 buffer (pH 
10.5) containing 2M NaCl. Samples were extracted again by liquid-liquid extraction 
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then centrifuged at 3000 rpm for 10 minutes and 1ml of organic layer was 
transferred to centrifuge tube, reduced to dryness at 23oC under vacuum. 500ul of 
45% methanol was added to the centrifuge tube, transferred to HPLC vials, and 
analyzed by HPLC(SHIMADZU) for product formation. The product of Nifedipine 
oxidation, oxidized Nifedipine, was monitored using the Shimadzu HPLC as 
described previously.  
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CHAPTER III 
RESULTS AND DISCUSSION 
 
3.1 Inhibition of CYP2E1 by Lemongrass oil and other essential oils 
3.1.1 Introduction 
The inhibition of CYP2E1 by natural compounds may have significant 
implications in the field of pharmacology or toxicology, given the role of this isoform 
in production of ROS or reactive drug metabolites. CYP2E1 metabolizes and activates 
many toxicological substrates to more toxic products and the induction of CYP2E1 by 
ethanol is thought to result in increased oxidative stress in hepatocytes. One proposed 
mechanism for this increased oxidative stress is the increased production of hydrogen 
peroxide by CYP2E1 via uncoupling of its NADPH oxidation activity. The main 
hypothesis of this thesis is that the main aldehyde constituent found in Lemongrass, 
Citral, will be able to block the activity of CYP2E1, and demonstrate physiologica 
antioxidant properties. For this reason we initiated studies to probe the interaction 
between a variety of oils and pure aldehydes with CYP2E1, specifically to determine 
whether these oils or aldehydes possessed inhibitory properties toward this enzyme. 
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Furthermore the mechanism of inhibition was also addressed. 
3.1.2 Michaelis-Menten kinetic analysis 
3.1.2.A. Inhibition of CYP2E1 by Lemongrass oil and the aldehyde citral 
Figure 4 and figure 5 show the results of inhibition studies carried out by using 
a single dose of Lemongrass oil of 5ug/ml. The final concentration of p-nitrophenol 
in the reaction was (10-100uM) and that of NADPH was 1.0mM. The 
Michaelis-Menten plot for Lemongrass (shown in Fig.4) shows significant enzyme 
inhibition across the entire range of substrate concentrations used. Because of the 
selectivity of CYP2E1 in the human liver microsomes for p-nitrophenol, the 
inhibition effect observed must be due to reduction in activity of this isoform. The 
observed value for Vmax of 59 and KM of 87 in the presence of inhibitor compared 
to the control Vmax of 76 and KM of 16 suggest a competitive type inhibition. The 
K I value was evaluated using the equation KM’= M(1+[I]/K I) and was found to be 
1.1ug/ml. The lineweaver-Burk plot (Fig.5) although the curves do not cross 
precisely at the Y axis is consistent with the competitive model of inhibition.  
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Figure 4. Michaelis-Menten plot of 50mM p-nitrophenol oxidation by CYP2E1 and 
inhibition by 5ug/ml Lemongrass oil in 20ul human liver microsomes. Each data 
point is the average of two samples. 
 
Figure 5. The Lineweaver-Burk plot of p-nitrophenol oxidation by CYP2E1 and 
inhibition by 5ug/ml Lemongrass oil in 20ul human liver microsomes, the x-axis= 
1/(S) and the y-axis=1/(V), each data point is the average of two samples. 
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 (1/relative activity) 
 Relative 
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Figure 6 and figure 7 show the results of inhibition studies carried out using a 
single dose of the aldehyde citral of 0.033mM. The final concentration of 
paranitrophenol in the reaction was (10-100uM) and that of NADPH was 1.0mM. 
The Michaelis-Menten plot for the aldehyde citral (shown in Fig.6) shows 
significant enzyme inhibition across the entire range of substrate concentrations used. 
The observed value for Vmax of 58 and KM of 98 in the presence of inhibitor 
compared to the control Vmax of 87 and KM of 21 suggest a competitive type 
inhibition. The KI value was evaluated using the equation KM’= M(1+[I]/K I) and 
was found to be 1.4ug/ml which correspond to KI value 9.0uM. The 
lineweaver-Burk plot(Fig.7) although the curves do not cross precisely at the Y axis
is consistent with the competitive model of inhibition.  
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Figure 6. Michaelis-Menten plot of 50mM p-nitrophenol oxidation by CYP2E1 and 
inhibition by 0.033mM the aldehyde citral in 20ul human liver microsomes. Each 
data point is the average of two samples. 
 
Figure 7. The Lineweaver-Burk plot of p-nitrophenol oxidation by CYP2E1 and 
inhibition by the 0.033mM aldehyde citral in 20ul human liver microsomes, the 
x-axis= 1/(S) and the y-axis=1/(V), each data point is the average of two sample. 
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3.1.2.B. Inhibition of CYP2E1 by Eucalyptus Lemon oil, Citronella oil, and the 
aldehyde citronellal 
Figure 8 shows the results of inhibition studies carried out using a single dose 
of the Eucalyptus Lemon oil of 5ug/ml. The final concentration of p-nitrophenol in 
the reaction was (10-100uM) and that of NADPH was 1.0mM. The 
Michaelis-Menten curve shows a little enzyme inhibition to CYP2E1. The obsrved 
value for Vmax of 134 and KM of 47 in the presence of inhibitor compared to the 
control Vmax of 130 and KM of 32 suggest a competitive type inhibition. The KI 
value was evaluated using the equation KM’= M(1+[I]/K I) and was found to be 
3.4ug/ml.  
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Figure 8. Michaelis-Menten plot of 50mM p-nitrophenol oxidation by CYP2E1 and 
inhibition by 5ug/ml Eucalyptus Lemon oil in 20ul human liver microsomes. Each 
data point is the average of two samples. 
 Relative 
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Figure 9 shows the results of inhibition studies carried out using a single dose 
of the Citronella oil of 5ug/ml. The final concentration of p-nitrophenol in the 
reaction was (10-100uM) and that of NADPH was 1.0mM. The Michaelis-Menten 
curve shows slight enzyme inhibition for the citronella oil. The observed value for 
Vmax of 149 and KM of 55 in the presence of inhibitor compared to the control 
Vmax of 149 and KM of 29 suggest a competitive type inhibition. The KI value was 
evaluated using the equation KM’=KM(1+[I]/K I) and was found to be 5.6ug/L. 
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Figure 9. Michaelis-Menten plot of 50mM p-nitrophenol oxidation by CYP2E1 and 
inhibition by 5ug/ml Citronella oil in the 20ul human liver microsomes. Each data 
point is the average of two samples. 
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Figure 10 shows the results of inhibition studies carried out using a single dose 
of the Citronellal of 5ug/ml. The final concentration of p-nitrophenol in the reaction 
was (10-100uM) and that of NADPH was 1.0mM. The Michaelis-Menten plot for 
Citronellal (shown in Fig.10) shows slightly enzyme inhibition across the entire 
range of substrate concentrations used. The observed value for Vmax of 136 and KM 
of 86 in the presence of inhibitor compared to the control Vmax of 121 and KM of 35 
suggest a competitive type inhibition. The KI value was evaluated using the equation 
KM’=KM(1+[I]/K I) and was found to be 3.4ug/ml. 
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Figure 10. Michaelis-Menten plot of 50mM p-nitrophenol oxidation by CYP2E1 and 
inhibition by 5ug/ml Citronellal in 20ul human liver microsomes. Each data point is 
the average of two samples. 
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3.1.2.C. Inhibition of CYP2E1 by Eucalyptus Globulous oil and it’s main 
constituent 1,8 Cineole 
Figure 11 shows the results of inhibition studies carried out using a single dose 
of the Eucalyptus Globulous oil of 5ug/ml. The final concentration of p-nitrophenol 
in the reaction was (10-100uM) and that of NADPH was 1.0mM. The 
Michaelis-Menten plot for Eucalyptus Globulous oil (shown in Fig.11) shows very 
little enzyme inhibition across the entire range of substrate concentratio s used. In 
fact the observed value for Vmax of 150 and KM of 40 in the presence of inhibitor 
compared to the control Vmax of 162 and KM of 39 suggest Eucalyptus globulous, at 
this concentration does not significantly affect the activity of CYP2E1. This is in 
contrast to earlier studies performed in this lab during a random screening of oils. It 
is possible that the Eucalyptus globulous oil contains unstable compounds that 
inhibit CYP2E1. Upon storage these compounds degrade. 
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Figure 11. Michaelis-Menten plot of 50mM p-nitrophenol oxidation by CYP2E1 and 
inhibition by 5ug/ml Eucalyptus Globulous oil in 20ul human liver microsomes. 
Each data point is the average of two samples. 
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Figure 12 shows the results of inhibition studies carried out using a single dose 
of the 1,8 Cineole of 5ug/ml. The final concentration of p-nitrophenol in the reaction 
was (10-100uM) and that of NADPH was 1.0mM. The Michaelis-Menten plot for 
1,8 Cineole (shown in Fig.12) shows no enzyme inhibition across the entire range of 
substrate concentrations used. The observed value for Vmax of 99 and KM of 30 in 
the presence of inhibitor compared to the control Vmax of 104 and KM of 31. 
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Figure 12. Michaelis-Menten plot of 50mM p-nitrophenol oxidation by CYP2E1 and 
inhibition by 5ug/ml 1,8 Cineole in 20ul human liver microsomes. Each data point is 
the average of two samples. 
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3.1.2.D. Inhibition of CYP2E1 by Cassia oil 
Figure 13 shows the results of inhibition studies carried out using a single dose 
of the Cassia oil of 5ug/ml. The final concentration of p-nitrophenol in the reaction 
was (10-100uM) and that of NADPH was 1.0mM. The Michaelis-Menten plot for 
Cassia oil (shown in Fig.13) shows a little enzyme inhibition across the entirrange 
of substrate concentrations used. The observed value for Vmax of 146 and KM of 46 
in the presence of inhibitor compared to the control Vmax of 142 and KM of 25 
suggest a competitive type inhibition. The KI value was evaluated using the equation 
KM’=KM(1+[I]/K I) and was found to be 6.0ug/ml.  
0 20 40 60 80 100
0
40
80
120
160
200
CONT ROL Cassiar elat ive act ivit y
PNP Concent r at ion
Michaelis-Menten of Cassia
 
Figure 13. Michaelis-Menten plot of 50mM p-nitrophenol oxidation by CYP2E1 and 
inhibition by 5ug/ml Cassia oil in 20ul human liver microsomes. Each data point is 
the average of two samples. 
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3.1.2.E. Inhibition of CYP2E1 by the aldehyde decanal 
Figure 14 and figure 15 shows the results of inhibition studies carried out using 
a single dose of Decanal of 5ug/ml. The final concentration of p-nitrophenol in the 
reaction was (10-100uM) and that of NADPH was 1.0mM. The Michaelis-Menten 
plot for Decanal (shown in Fig.14) shows that decanal is a very efficient inhibitor of 
CYP2E1 at this dose. The observed value for Vmax of 81 and KM of 177 in the 
presence of inhibitor compared to the control Vmax of 113 and KM of 40 suggest a 
competitive type inhibition. The KI value was evaluated using the equation 
KM’=KM(1+[I]/K I) and was found to be 2.6ug/ml. The lineweaver-Burk plot (Fig.15) 
although the curves do not cross precisely at the Y axis is consistent with the 
competitive model of inhibition.  
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Figure 14. Michaelis-Menten plot of 50mM p-nitrophenol oxidation by CYP2E1 and 
inhibition by 5ug/ml Decanal in 20ul human liver microsomes. Each data point is 
the average of two samples. 
 
Figure 15. The Lineweaver-Burk plot of p-nitrophenol oxidation by CYP2E1 and 
inhibition by 5ug/ml Decanal in 20ul human liver microsomes, the x-axis= 1/(S) and 
the y-axis=1/(V), each data point is the average of two samples. 
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Essential oils and aldehydes  KI values   ug/ml  
The aldehyde Citral  1.4  
Lemongrass oil  1.1  
The aldehyde Citronellal 3.4 
Citronella oil  5.6  
Eucalyptus lemon oil  3.5  
The aldehyde Decanal  2.6 
1,8 Cineole  N/A  
Eucalyptus globulous oil  N/A  
Cassia oil  6.0  
Table 2. KI values of essential oils and the aldehydes 
 
 
 
 
44 
 
3.2 Growth and treatment of HepG2 cells 
This experiment was to show Lemongrass oil,which contains the aldehyde 
constituent Citral, can activate the antioxidant response elements found in a variety of 
antioxidant/phase II drug metabolizing genes. In order to demonstrate the induction of 
phase II genes, cultured human liver cells, HepG2 cells, were used to test the 
induction of genes of interest and these cells were treated with Lemongrass oil nd the 
aldehyde citral. The RT-PCR and gel electrophoresis were used to monitor antioxidant 
genes expression. 
3.2.1. The gel electrophoresis result                                       
 
 
 
Figure 16. 1.5% agarose gel showing the resulting band from RT-PCR amplification 
of β-actin RNA produced in HepG2 cells with increasing doses of Lemongrass oil. 
Lanes 3-6 correspond to doses of 0ug/ml, 20ug/ml, 50ug/ml, and 200ug/ml 
Lemongrass, respectively.  
  
 
Lane 1 Lane2   Lane3  Lane4  Lane5  Lane6 
250bp 
300bp 
200bp 
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Figure 16 shows the transcriptional level of β-actin-1 with increasing doses of 
the Lemongrass oil applied to the HepG2 cells. Based on visual inspection of the 
bands, the β-actin levels appear to be similar, although lane6 may be slightly less 
intense than the others, which may suggest a small change in expression of β-actin at 
the very highest concentration of oil. Lane1 is the DNA ladder, lane 2 is also DNA 
ladder, lane3 is the control without Lemongrass, lane4 is the sample of HepG2 cell 
treated with 0.02 ug/ml of Lemongrass oil, lane5 is the sample of HepG2 cell treated 
with 0.05 ug/ml of Lemongrass oil, lane 6 is the sample of HepG2 cell treated with 
0.2 ug/ml of Lemongrass oil. β-actin in each sample was confirmed by the presence of 
a PCR product at just under 300bp in length. Several experimental conclusions had to 
be tested before consistent amplification of the β-actin gene was observed, more 
importantly the most effective annealing temperature for the PCR was determined to 
be 56 oC. 
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Figure 17. 1.5% agarose gel showing the resulting band from RT-PCR amplification 
of β-actin RNA produced in HepG2 cells at 20ug/ml Lemongrass oil time-dependent 
experiment. Lanes 2-5 correspond to the time of 0hr, 2hrs, 6hrs, and 24hrs 
respectively.  
 
 Figure 17 shows the expression of β-actin-1 for time dependent when HepG2 
cells were treated with 20ug/ml Lemongrass oil. In this experiment lane1 is the DNA 
ladder, lane2 is the HepG2 cells treated with Lemongrass oil at 20ug/ml for 0hr 
incubation, lane3 is the HepG2 cells treated with Lemongrass oil at 20ug/ml for 1hr
incubation, lane4 is the HepG2 cells treated with Lemongrass oil at 20ug/ml for 6hr
incubation, lane5 is the induction of HepG2 cells treated with Lemongrass oil at 
20ug/ml for 24hr incubation post treatment. It appeared that the intensity of 4 bands 
were uneven, however, lane 4 had lower intensity compared to the other lanes, which 
may be the result of artifact, perhaps loading error. And lane 5 had stronger intensity 
which could be the number of the cells were more than the other samples.  
Lane 1     Lane2   Lane3   Lane4     Lane 5  
 
250bp 
47 
 
 
Figure 18. 1.5% agarose gel showing the resulting band from RT-PCR amplification 
of β-actin RNA produced in HepG2 cells with increasing doses of the aldehyde citral. 
Lanes 3-6 correspond to doses of 0ug/ml, 20ug/ml, 50ug/ml, and 200ug/ml citral, 
respectively.  
 
 Figure 18 showed the expression of β-actin-1 for dose dependent when treated 
the aldehyde citral to the HepG2 cells. Lane1 and lane2 are the DNA ladders, lan 3 is 
the control without the aldehyde citral, lane4 is the HepG2 cells treated with 20 ug/ml 
of the aldehyde citral, lane5 is the HepG2 cells treated with 50 ug/ml of thealdehyde 
citral, lane6 is the HepG2 cells treated with 200 ug/ml of the aldehyde citral.  
There is a slight stronger intensity in both lane3 and lane 4 with increasing 
concentration. All the expression of β-actin-1 are much stronger than the control, it 
could be the artifact of gel loading or the cell numbers were lower in the control cells 
than the other cells, which make β-actin-1 expression slightly less intense. 
 
 
Lane 1 Lane2Lane3 Lane4 Lane5 Lane6 
300bp 
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Figure 19. 1.5% agarose gel showing the resulting band from RT-PCR amplification 
of β-actin RNA produced in HepG2 cells at 20ug/ml Citral time-dependent 
experiment. Lanes 2-5 correspond to the time of 0hr, 2hrs, 6hrs, and 24hrs 
respectively.  
 
 Figure 19 shows the expression of β-actin-1 for time dependent when HepG2 
cells were treated with 20ug/ml Citral. In this experiment lane1 is the DNA ladder, 
lane2 is the HepG2 cells treated with Citral at 20ug/ml for 0hr incubation, lane3 is the 
HepG2 cells treated with Citral at 20ug/ml for 2hrs incubation, lane4 is the HepG2 
cells treated with Citral at 20ug/ml for 6hrs incubation, lane5 is the induction of 
HepG2 cells treated with Citral at 20ug/ml for 24hrs incubation post treatment. There 
is a increasing trend of β-actin expression with increasing time of citral treated which 
may be the numbers of cells were different and made the expression of β-actin
uneven. 
 
  Lane 1   Lane2  Lane3  Lane4  Lane5 
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Figure 20. 1.5% agarose gel showing the resulting band from RT-PCR amplification 
of HO-1 RNA produced in HepG2 cells with increasing doses of Lemongrass oil. 
Lanes 2-5 correspond to doses of 0ug/ml, 20ug/ml, 50ug/ml, and 200ug/ml 
Lemongrass, respectively.  
 
 Figure 20 shows the transcriptional level of HO-1 with doses increasing of the
Lemongrass oil applied to the HepG2 cells. Based on visual inspection of the bands, 
the HO-1 expression levels appear to be increased with increasing concentration of 
lemongrass. Lane1 is the DNA ladder, lane2 is the control without Lemongrass, lane3 
is the sample of HepG2 cell treated with 20 ug/ml of Lemongrass oil, lane4 is the
sample of HepG2 cell treated with 50 ug/ml of Lemongrass oil, lane 5 is the sample of 
HepG2 cell treated with 200 ug/ml of Lemongrass oil. HO-1 in each sample was 
confirmed by the presence of a PCR product at just 270bp in length. The most 
effective annealing temperature for PCR was determined to be 55 oC. When compared 
with β-actin expression in the dose dependent experiment, HO-1 expression appeared 
     Lane 1  Lane2  Lane3  Lane4 Lane5 
 250bp 
50 
 
to increase with increasing dose of lemongrass. This may also correspond to 
increasing antioxidant properties induced by lemongrass oil.  
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Figure 21. 1.5% agarose gel showing the resulting band from RT-PCR amplification 
of HO-1 RNA produced in HepG2 cells at 20ug/ml Lemongrass oil time-dependent 
experiment. Lanes 2-5 correspond to the time of 0hr, 2hrs, 6hrs, and 24hrs 
respectively.  
 
 Figure 21 shows the expression of HO-1 for time dependent when HepG2 cells 
were treated with 20ug/ml Lemongrass oil. In this experiment lane1 is the DNA 
ladder, lane2 is the HepG2 cells treated with Lemongrass oil at 20ug/ml for 0hr 
incubation, lane3 is the HepG2 cells treated with Lemongrass oil at 20ug/ml for 2hr 
incubation, lane4 is the HepG2 cells treated with Lemongrass oil at 20ug/ml for 6hr
incubation, lane5 is the induction of HepG2 cells treated with Lemongrass oil at 
20ug/ml for 24hr incubation post treatment. The bands here appeared to be constant 
brightness with increasing time of HepG2 cells treated with Lemongrass oil. The 
result indicates that lemongrass did not have an inductive effect at this dose over a 24 
hr period. Because the HO-1 expression in this figure remain constant along with 
increasing times of lemongrass treating. In looking at the previous figure, it is not 
totally unexpected, as the dose of 20ug/ml appears to be below the effective dose. 
 Lane 1  Lane2  Lane3  Lane4   Lane5 
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Therefore, to examine the time dependence of this induction, future studies should be 
carried out at 100ug/ml or higher. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
53 
 
 
 
Figure 22. 1.5% agarose gel showing the resulting band from RT-PCR amplification 
of HO-1 RNA produced in HepG2 cells with increasing doses of the aldehyde citral. 
Lanes 2-5 correspond to doses of 0ug/ml, 20ug/ml, 50ug/ml, and 200ug/ml citral, 
respectively.  
 
 Figure 22 shows the expression of HO-1 with doses increasing of the aldehyde 
citral applied to the HepG2 cells. Lane1 is the DNA ladder, lane2 is the control 
without citral, lane3 is the sample of HepG2 cell treated with 20 ug/ml of citral, lane4 
is the sample of HepG2 cell treated with 50 ug/ml of citral, lane 5 is the sample of 
HepG2 cell treated with 200 ug/ml of citral. HO-1 in each sample was confirmed by 
the presence of a PCR product at just 270bp in length. In lane 3, it shows a strongest 
HO-1 expression in 20ug/ml of citral compared to the higher dose in the lane 4 and 
lane 5. It may suggest that 20ug/ml is the most effective dose for the induction of 
antioxidant property. Citral is, in fact, known to kill cancer cells at elevated doses. 
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Figure 23. 1.5% agarose gel showing the resulting band from RT-PCR amplification 
of HO-1 RNA produced in HepG2 cells at 20ug/ml the aldehyde citral time-dependent 
experiment. Lanes 2-5 correspond to the time of 0hr, 2hrs, 6hrs, and 24hrs 
respectively.  
 
 Figure 23 shows the expression of HO-1 for time dependent when HepG2 cells 
were treated with 20ug/ml the aldehyde citral. In this experiment lane1 is the DNA 
ladder, lane2 is the HepG2 cells treated with the aldehyde citral at 20ug/ml for 0hr 
incubation, lane3 is the HepG2 cells treated with the aldehyde citral at 20ug/ml for 
2hr incubation, lane4 is the HepG2 cells treated with the aldehyde citral at 20ug/ml 
for 6hr incubation, lane5 is the induction of HepG2 cells treated with the aldehyde 
citral at 20ug/ml for 24hr incubation post treatment. Both lane 3 and lane 4 have the 
same intensity of HO-1 expression compare to lane 1 and lane 4, it shows that with 2 
and 6 hours citral treating, there is a stronger antioxidant property. Moreover the 
effect of antioxidant may be lesser when the cell treated with citral for 24 hours, 
probably due to metabolism of the citral. Liver enzymes, including cytochrome 
 Lane 1 Lane2 Lane3 Lane4 Lane5 
 250bp 
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P450’s, are known to degrade this compound in a matter of hours. 
3.3 Inhibition of CYP3A4 by nifedipine oxidation 
 The assay for monitoring CYP3A4 were developed utilizing the specific abil ty 
of this enzyme to oxidize nifedipine and rat microsomes were used in the assay. 
Experiments were carried out in the absence and presence of NADPH for identifyng 
the peak of oxidized nifedipine on the chromatogram. The experimental procedure 
used for the evaluation of CYP3A4 inhibition was as follows: Along with 20ul of rat 
microsomes, 50ul of 1M potassium phosphate buffer solution (pH 7.4), 40ul of 1mM 
Nifedipine and deionized water were initially combined in a final volume of 0.5ml. 
25ul of 1mM NADPH was added to initiate the reaction in a 37oC water bath for 10 
minutes, then the reaction was quenched with the addition of 1ml of dichloromethane 
and 100ul of 1M Na2CO3 buffer (pH 10.5) containing 2M NaCl. Samples were 
extracted by liquid-liquid extraction then centrifuged at 3000 rpm for 10 minutes and 
1ml of organic layer was transferred to centrifuge tube, reduced to dryness at 23oC 
under vacuum, added 500ul of 45% methanol to centrifuge tube, transferred to HPLC 
vials, and analyzed by HPLC(SHIMADZU) for product formation. The product of 
Nifedipine oxidation, oxidized Nifedipine, was monitored using a Shimadzu LC 20A 
Series HPLC system consisting of an SPD-20A UV/Vis detector, LC 20AT solvent 
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delivery, and a Sil 20A autosampler, all controlled using the Shimadzu EZStart 
version 7.3 SP1 software. Absorbance detection was set to 254 nm with a mobile 
phase consisting of 60% methanol, 40% H2O, 0.5% acetic acid at a flow rate of 
0.6ml/min. The volume of injection was 40 ul for each sample and the column was a 
RP-C18 HPLC column. All assays were carried out in duplicate. 
3.3.1. The retention time of Nifedipine and Oxidized nifedipine was identified 
 Figure 24 shows the peaks of standard oxidized nifedipine and standard 
nifedipine on the HPLC with UV detection. The peak at 4.0 minute was identified as 
the retention time of standard oxidized nifedipine using an authentic standard 
purchased for Oxford Biomedical and the peak at 6.2 minute was identified as the 
retention time of nifedipine. 
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Figure24. HPLC-UV chromatogram of standard oxidized nifedipine(4.0minute) and 
nifedipine(6.2minute). Absorbance detection was set to 254 nm with a mobile phase 
consisting of 60% methanol, 40% H2O, 0.5% acetic acid at a flow rate of 0.6ml/min. 
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Figure 25 shows the HPLC chromatogram of 40ul of 1mM of nifedipine 
combined with 20ul of rat microsomes, 50ul of 1.0M potassium phosphate buffer 
solution (pH 7.4), and deionized water in a final volume of 0.5ml. The reaction was 
incubated at 37oC water bath for 10 minutes, then the reaction was quenched with the 
addition of 1ml of dichloromethane and 100ul of 1M Na2CO3 buffer (pH 10.5) 
containing 2M NaCl. Samples were extracted by liquid-liquid extraction the
centrifuged at 3000 rpm for 10 minutes and 1ml of organic layer was transferred to 
centrifuge tube, reduced to dryness at 23oC under vacuum, 500ul of 45% methanol 
was added to centrifuge tube, the contents were transferred to HPLC vials, and 
analyzed by HPLC(SHIMADZU) for product formation. In figure 25, the peak of 
nifedipine matched with figure 24 in the same retention time and the peak of oxidized 
nifedipine was undetectable because of no NADPH in the reaction. 
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Figure25. HPLC-UV chromatogram of nifedipine(6.2minute) when the reaction 
incubated without the addition of NADPH. Absorbance detection was set to 254 nm 
with a mobile phase consisting of 60% methanol, 40% H2O, 0.5% acetic acid at a 
flow rate of 0.6ml/min. 
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Figure 26 shows the HPLC chromatogram of 40ul of 1mM of nifedipine 
combined with 20ul of rat microsomes, 50ul of 1M potassium phosphate buffer 
solution (pH 7.4), 0.2mM nifedipine, and deionized water in a final volume of 0.5ml. 
The reaction was incubated at 37oC water bath for 10 minutes, then the reaction was 
quenched with the addition of 1ml of dichloromethane and 100ul of 1M Na2CO3 
buffer (pH 10.5) containing 2M NaCl. Samples were extracted by liquid-liquid 
extraction then centrifuged at 3000 rpm for 10 minutes and 1ml of organic layer was 
transferred to centrifuge tube, reduced to dryness at 23oC under vacuum, added 500ul 
of 45% methanol to centrifuge tube, transferred to HPLC vials, and analyzed by 
HPLC(SHIMADZU) for product formation. In the figure 26, the peak of oxidized 
nifedipine and nifedipine were match with the figure 24 at the same retention time. In 
the reaction, nifedipine was oxidized by CYP3A4 and formed the product of oxidized 
nifedipine when the reaction incubated with the addition of NADPH. 
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Figure26. HPLC-UV chromatogram of oxidized nifedipine when the reaction 
incubated with the addition of NADPH(4.0minute) and nifedipine(6.2minute). 
Absorbance detection was set to 254 nm with a mobile phase consisting of 60% 
methanol, 40% H2O, 0.5% acetic acid at a flow rate of 0.6ml/min. 
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3.3.2. The screen experiments of nifedipine oxidation by CYP3A4 with and 
without Lemongrass oil and the aldehyde citral 
 Figure 27 shows the percentage of inhibition with Lemongrass added in the 
reaction of oxidation of nifedipine. Over 50% of inhibition of activity was observed 
by adding only 5ul of the diluted Lemongrass oil. 5ul of Lemongrass oil was diluted 
into 100ml deionized water. The final concentration of Lemongrass oil was 0.5ug/ml, 
5ug/ml, and 35ug/ml. From the figure it is apparent that at relatively low doses, the 
lemongrass oil had a significant inhibitory effect on the activity of CYP3A4. For 
example, a 5ug/ml dose reduced the activity by more than 50%. This corresponds to a 
solution that is the equivalent of 5mg(~5ul) diluted to 10L with water. 
 
Figure 27. The screen experiment of Lemongrass oil with 0ul, 5ul, 50ul, and 350ul 
correspond to the oil concentration of 0ug/ml, 0.5ug/ml, 5ug/ml, and 35ug/ml 
respectively. 
(Activity)  
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 The potent inhibition of CYP3A4 by lemongrass oil, combined with the high 
content of citral in lemongrass led us to look at the ability of this naturally occurring 
aldehyde with regard to its inhibition of CYP3A4 using similar doses of citral, 
ranging from 0ug/ml, 0.5ug/ml, 5ug/ml, and 35ug/ml, the activity of CYP3A4 was 
monitored as in the previous section. Figure 28 shows the percentage of inhibition 
with the aldehyde citral added in the reaction of oxidation of nifedipine. Over 50% of 
inhibition of activity was observed by adding only 5ul of the diluted citral. 5ul of 
citral was diluted into 100ml deionized water. The final concentration of citral was 
0.5ug/ml, 5ug/ml, and 35ug/ml. As with lemongrass, the citral was a very potent 
inhibitor of CYP3A4, even more so than lemongrass. At the lowest dose used, 5ug/ml, 
only 30% of the activity of the enzyme remained. This dose corresponds to a 
concentration of 3.3uM. Based on this potent inhibition, the inhibition of CYP3A4 by 
this common food additive may have significant pharmacological consequences. 
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Figure28. The screen experiment of citral with 0ul, 5ul, 50ul, and 350ul correspond to 
the oil concentration of 0ug/ml, 0.5ug/ml, 5ug/ml, and 35ug/ml respectively. 
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CHAPTER IV 
DISCUSSION 
 
 From the Michaelis-Menten plots for inhibition of CYP2E1, there was a 
correlation seen between the aldehyde content and the potency with regard to 
cytochrome P4502E1 inhibition. Lemongrass, which contains the unsaturated aldehyde 
citral, showed a significant level of cytochrome CYP2E1 inhibition. The essential oil 
of lemongrass contains very high amounts of the aldehyde citral, which is the name 
for the pair of cis, trans isomers neral and geranial. Citral is an α,β-unsaturated 
aldehyde and has been shown to possess anti-inflammitory properties tha  may relate 
to its ability to control redox balance within the cell.  The anti-inflammitory response 
results from suppression of iNOS expression and NF-kB activation.  The relationship 
of both of these aldehydes to a reduction in oxidative stress and their ability to inhibit 
the human cytochrome P4502E1 isoform suggests that the two effects may be related, 
given the involvement of this isoform in initiating lipid peroxidation. 
According to my experimental data and gel electrophoresis experimental results, the 
HO-1 showed significant increased expression in human liver cells in response to 
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increasing concentrations of both Lemongrass oil and the aldehyde citral. Furthermore, 
the time-dependence experiment for both Lemongrass oil and the aldehyde citral also 
showed the levels of mRNA for these genes increased in a time dependent manner up 
to 8 hrs incubation. For the gene expression of HO-1, in the dose-dependenc  
experiment, it showed an increasing trend with respective to the increasing 
concentration of Lemongrass oil and the aldehyde citral in the agarose gel 
electrophoresis from the control sample to the highest concentration one, which 
directly validated that the presence of Lemongrass oil induced phase II detoxyfying 
genes in the HepG2 cells with increasing doses. It also assertively demonstrated the 
hypothesis that Citral which is a component of Lemongrass oil playsthe major role of 
the induction of phase II detoxyfying genes. In the dose-dependence experiment, 
Citral caused significant increases in the expression of HO-1 genes. This experimental 
result suggests that the Citral is the main component of Lemongrass which induces 
the expression of HO-1. From prior studies we know the activation of HO-1 is a 
ubiquitous cellular response to oxidative stress, which produces ROS, such a  
hydrogen peroxide and ultimately leads to lipid peroxidation. The expression of HO-1 
gene is related to the production of biliverdin and its subsequent metabolite bilirubin, 
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both products have antioxidant properties against oxidative stress caused by 
xenobiotics, oxidants, UV light, and radiation (33). In addition to the dose-ep ndent 
experiment, I also performed time-dependent experiment to show the time manner of 
the induction of HO-1. With the different period of time, the bands showed stronger 
band with increasing time of oil treatment in both Lemongrass oil and Citral in the gel 
electrophoresis up to 8hrs. The 24hr time resulted in a return to basal expression 
levels, which may result from the metabolism of control over that time period. This 
experiment results lead to the conclusion that with the same concentration of oil but 
different time treating periods, the induction of HO-1 is time dependent.  
In the method development of CYP3A4 inhibition assay, CYP3A4 is the enzyme to 
metabolize Nifedipine to oxidized nifedipine. In order to identify the retention time of 
Nifedipine and oxidized nifedipine, standard compounds of both Nifedipine and 
oxidized nifedipine were acquired and injected onto HPLC and the retention time of 
both compounds were determined using a variety of different mobile phases. After 
identification of the peaks of Nifedipine and oxidized nifedipine and determination of 
the exact retention time on the chromatogram, incubations were performed to 
demonstrate the Nifedipine was oxidized to oxidized nifedipine by using 5 different 
microsomes which included human liver microsomes, rabbit liver microsomes 1, 
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rabbit liver micorsomes 2, rat liver microsomes and supersomes which is enriched of 
CYP3A4. The chromatograms showed that there was a significant absorbance for 
oxidized nifedipine in the retention time of 3.8minutes with the presence of 
supersomes and rat liver microsomes when the NADPH was added in the reaction. In 
the human liver microsomes and rabbit liver microsomes 1, there was very little or no 
significant difference for both with NADPH and without NADPH reaction. Finally, it 
was shown that both lemongrass and citral inhibit CYP3A4 significantly at very low 
micromolar concentrations. This may have very important implications in drug 
metabolism as CYP3A4 is extremely important pharmacologically, in that it is 
responsible for metabolism of nifedipine. 
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